Idarucizumab, a humanized, monoclonal antibody fragment for immediate reversal of dabigatran
Objective: To evaluate the role of idarucizumab, a humanized monoclonal antibody fragment, as a specific reversal agent for the anticoagulant activity of dabigatran and to review the pharmacology, pharmacokinetic properties, efficacy, and safety of this agent. Methods: A literature search was conduc...
Saved in:
| Main Author: | Kuyumjian, Yara (author) |
|---|---|
| Other Authors: | Miyares, Marta A. (author), Eaves, Shannon (author) |
| Format: | article |
| Published: |
2015
|
| Online Access: | http://hdl.handle.net/10725/6127 http://dx.doi.org/10.1177/0897190015615248 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php http://journals.sagepub.com/doi/pdf/10.1177/0897190015615248 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Idarucizumab for Reversal of Dabigatran
by: Sheikh‑Taha, Marwan
Published: (2019) -
Reversal of dabigatran requiring hemodialysis, fresh frozen plasma, and 2 doses of idarucizumab in a patient with acute kidney injury
by: Sheikh-Taha, Marwan
Published: (2018) -
Anti-amyloid monoclonal antibody therapies in Alzheimer’s disease – a scoping review
by: Shahd Abubaker Elamin (22569539)
Published: (2025) -
Novel Federated Decision Making for Distribution of Anti-SARS-CoV-2 Monoclonal Antibody to Eligible High-Risk Patients
by: AlSereidi, Abeer
Published: (2022) -
Federal Multi Criteria Decision Making Framework in Distribution of Anti-SARS-CoV-2 Monoclonal Antibody to Eligible High-Risk Patients as Case Study
by: ALSEREIDI, ABEER
Published: (2022)